New antihypertensive drug to be covered by health insurance as new substance

Recently, the Health Insurance Review Agency approved a local pharmaceutical company's antihypertensive drug as a new substance and the market for antihypertension medicines dominated by a multinational giant is expected to enter fierce competition.

We have acknowledged the Ahngook Pharm's levotension tablet (S-Amlodipine besylate) as a novel substance that is different from amlodipine besy...